Universal Genomic Testing: The next step in oncological decision-making or a dead end street?-Reference-Cited by-同舟云学术

Universal Genomic Testing: The next step in oncological decision-making or a dead end street?

Published:2017-09 Issue: Volume:82 Page:72-79
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Holch Julian Walter,Metzeler Klaus Hans,Jung Andreas,Riedmann Kristina,Jost Philipp Jakob,Weichert Wilko,Kirchner Thomas,Heinemann Volker,Westphalen Christoph Benedikt

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

4. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial;Le Tourneau;Lancet Oncol,2015

5. Emerging landscape of oncogenic signatures across human cancers;Ciriello;Nat Genet,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervical Cytology Preserves Histologically Detected Surface Epithelial Slackening, Unique to thePOLEMutation-subtype in Endometrial Cancer;In Vivo;2023-12-25

2. “Surface epithelial slackening” pattern in endometrioid carcinoma: A morphological feature for differentiating the POLE mutation-subtype from the no specific molecular profile subtype;Pathology - Research and Practice;2023-07

3. ATM immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma;Pathology - Research and Practice;2022-02

4. Development and Application of Patient-Derived Cancer Organoidsin Clinical Management of Gastrointestinal Cancer: A State-of-the-Art Review;Frontiers in Oncology;2021-10-29

5. Organoid Models for Cancer Research—From Bed to Bench Side and Back;Cancers;2021-09-26